T. Eichkorn

发表

Stereotactic radiosurgery for brain metastases from pelvic gynecological malignancies: oncologic outcomes, validation of prognostic scores, and dosimetric evaluation

A. Schneeweiss, J. Debus, L. König, 2021, International Journal of Gynecological Cancer.

Progression of Pulmonary Function and Correlation with Survival Following Stereotactic Body Radiotherapy of Central and Ultracentral Lung Tumors

J. Debus, Michael Thomas, R. E. El Shafie, 2020, Cancers.

Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme.

J. Debus, Michael Thomas, F. Weykamp, 2020, Clinical lung cancer.

Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.

K. Herfarth, M. Alber, J. Debus, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Return to Work, Fatigue and Cancer Rehabilitation after Curative Radiotherapy and Radiochemotherapy for Pelvic Gynecologic Cancer

M. Wallwiener, J. Debus, P. Hoegen, 2022, Cancers.

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns

J. Debus, D. Weber, R. E. El Shafie, 2020, Frontiers in Oncology.

Severe skin toxicity during whole-brain radiotherapy, targeted therapy, and additional drug intake including St. John’s wort skin oil

K. Herfarth, J. Debus, L. König, 2021, Strahlentherapie und Onkologie.

SMART ablation of lymphatic oligometastases in the pelvis and abdomen: Clinical and dosimetry outcomes.

J. Debus, F. Weykamp, L. König, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Iatrogenic Influence on Prognosis of Radiation-Induced Contrast Enhancements in Patients with Glioma WHO 1-3 following Photon and Proton Radiotherapy.

K. Herfarth, J. Debus, L. König, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

3D-printed individualized tooth-borne tissue retraction devices compared to conventional dental splints for head and neck cancer radiotherapy: a randomized controlled trial

K. Herfarth, J. Debus, K. Zaoui, 2021, Radiation oncology.

Effectiveness and Toxicity of Fractionated Proton Beam Radiotherapy for Cranial Nerve Schwannoma Unsuitable for Stereotactic Radiosurgery

K. Herfarth, J. Debus, R. E. El Shafie, 2021, Frontiers in Oncology.

Postoperative Radiotherapy and the Role of Regional Lymph Node Irradiation in Localized Merkel Cell Carcinoma: A Single-Center Retrospective Analysis

J. Debus, J. Hörner-Rieber, J. Hassel, 2022, Cancers.

Adaptive MR-Guided Stereotactic Radiotherapy is Beneficial for Ablative Treatment of Lung Tumors in High-Risk Locations

J. Debus, P. Hoegen, F. Weykamp, 2022, Frontiers in Oncology.

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

K. Herfarth, K. Schubert, J. Debus, 2023, Frontiers in Oncology.

Consolidation Immunotherapy After Platinum-Based Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer—Cross-Sectional Study of Eligibility and Administration Rates

J. Debus, Michael Thomas, C. Heussel, 2020, Frontiers in Oncology.

Upfront and Repeated Stereotactic Radiosurgery in Patients With Brain Metastases From NSCLC.

J. Debus, L. König, P. Christopoulos, 2023, Clinical lung cancer.

Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability

K. Herfarth, P. Plinkert, G. Dyckhoff, 2022, Radiation Oncology.

Carbon Ion Radiation Therapy: One Decade of Research and Clinical Experience at Heidelberg Ion Beam Therapy Center.

K. Herfarth, T. Haberer, J. Debus, 2021, International journal of radiation oncology, biology, physics.

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3

K. Herfarth, C. Jungk, J. Debus, 2023, Journal of Neuro-Oncology.

Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids

T. Welzel, J. Debus, P. Hoegen, 2023, Clinical and translational radiation oncology.

Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancer

J. Debus, A. Stenzinger, D. Kazdal, 2021, ESMO open.

Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification

David C. Jones, Sybren L. N. Maas, K. Herfarth, 2023, Neuro-oncology advances.

Oral Sequelae after Head and Neck Radiotherapy: RCT Comparing 3D-Printed Tissue Retraction Devices with Conventional Dental Splints

J. Debus, P. Rammelsberg, F. S. Schwindling, 2023, Journal of clinical medicine.

Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy

P. Hoegen, L. König, J. Hörner-Rieber, 2023, Radiation Oncology.

To Fly or not to Fly: Stereotactic MR-guided adaptive RadiotherapyEffectively Treats Ultracentral Lung Tumors with Favorable Long-Term Outcomes

J. Debus, P. Hoegen, F. Weykamp, 2023, Lung Cancer.

Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk

P. Haering, J. Debus, L. König, 2022, Cancers.